SINGAPORE, Nov. 4, 2025 /PRNewswire/ — HelloRide and Razer have unveiled Singapore’s first co-branded black-and-gold shared bicycles, blending mobility, lifestyle, and gaming to introduce a "ride-to-earn" concept. This initiative transforms daily commutes into interactive, reward-driven experiences.

The new fleet showcases Razer’s signature black-and-gold aesthetics combined with HelloRide’s blue, creating striking visual statements across the city. These bicycles serve as moving cultural symbols, merging premium design with everyday mobility.

Riders selecting the Razer bikes unlock exclusive digital benefits, including 8% cashback in Razer Gold and 1,000 Razer Silver points, redeemable for gaming gear and subscriptions. This partnership turns every ride into a rewarding journey.

Available to all HelloRide users in Singapore with no deposit or top-up required, the Razer x HelloRide bikes offer true pay-as-you-go rides starting from just $1. The fleet is conveniently stationed at high-traffic MRT stations, bus interchanges, lifestyle hubs, and along the Marina Bay waterfront, ensuring seamless access for commuters and leisure riders alike.

This collaboration promotes shared mobility adoption, helping reduce carbon emissions and urban congestion. By fusing sustainability, aspirational design, and digital incentives, HelloRide and Razer make green commuting a lifestyle choice, not just a necessity.

We invite you to experience this innovative partnership firsthand. Please contact us to schedule a ride and explore the future of urban mobility.

Contact: Paula Olaya, paula.olaya@heliosww.com

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Geotab and Logmaster collaborate to transform Australian trucking

A new commercial arrangement between Geotab and Logmaster combines Geotab’s world-leading telematics…

CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA

Sugemalimab is the world’s first anti-PD-L1 monoclonal antibody approved for the treatment…

RM30 Million TalentCorp Internship Matching Grant for SMEs and Start-ups

RM30 million fund for LiKES from TalentCorp for 3 years, from 2024-2026…